|
Wall Street Journal: Paramount Enters Exclusive Merger Talks with Skydance, Spurning $26 Billion Offer from Apollo
Jessica Toonkel and Miriam Gottfried report that Skydance CEO David Ellison and Paramount have entered exclusive merger talks – providing 30 days for both parties to reach a deal. Read More
Bloomberg: Vertex to Pay $4.9 Billion for Kidney Disease Drug Developer
In the company’s biggest acquisition ever, Vertex Pharmaceuticals agreed to buy Alpine Immune Sciences, a leading manufacturer of kidney disease treatments and therapies for nearly $5B. Read More
Wall Street Journal: Jersey Mike’s Considers Sale
Lauren Thomas breaks the news that the sandwich chain has conducted one-off discussions with Blackstone this spring valuing the company at $8B, nearly one year after Roark Capital acquired Subway for $9.6B - pricey subs! Read More
|